TITLE

EXPRESSION OF IL-17 IN VIRAL INDUCED DILATED CARDIOMYOPATHY MICE

PUB. DATE
October 2010
SOURCE
Heart;Oct2010 Supplement, pA48
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Expression of IL-17 in Viral Induced Dilated Cardiomyopathy Mice" by Lin Song and colleagues is presented.
ACCESSION #
66245526

 

Related Articles

  • Inhibition of encephalomyocarditis virus replication by shRNA targeting 1D and 3AB genes in vitro and in vivo. Bai, Juan; Jiang, Kangfu; Zeshan, Basit; Wang, Xianwei; Li, Yufeng; Jiang, Ping // Virus Genes;Apr2012, Vol. 44 Issue 2, p183 

    Encephalomyocarditis virus (EMCV) could infect many host species and cause acute myocarditis and sudden death in pre-weaned piglets. It was necessary to develop new antiviral strategies for the treatment of the virus infection. Here, four plasmids expressing shRNA (small hairpin RNA) targeted to...

  • EXPRESSION OF TUMOUR NECROSIS FACTOR-α CONVERTING ENZYME AND TUMOUR NECROSIS FACTOR-α IN RATS WITH ALCOHOLIC CARDIOMYOPATHY.  // Heart;Oct2010 Supplement, pA49 

    An abstract of the article "Expression of Tumour Necrosis Factor-α Converting Enzyme and Tumour Necrosis Factor-α in Rats with Alcoholic Cardiomyopathy" by Li Jianqiang and colleagues is presented.

  • Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function.  // BMC Medicine;2012, Vol. 10 Issue 1, p40 

    The article focuses on a study that was designed to evaluate the impact of ALDH2 on streptozotocin-induced diabetic cardiomyopathy. Friendly virus B(FVB) and ALDH2 transgenic mice were treated with streptozotocin to induce diabetes.Echocardiographic evaluation revealed reduced fractional...

  • Worsening of Cardiomyopathy Using Deflazacort in an Animal Model Rescued by Gene Therapy. Rotundo, Ida Luisa; Faraso, Stefania; De Leonibus, Elvira; Nigro, Gerardo; Vitiello, Carmen; Lancioni, Alessio; Di Napoli, Daniele; Castaldo, Sigismondo; Russo, Vincenzo; Russo, Fabio; Piluso, Giulio; Auricchio, Alberto; Nigro, Vincenzo // PLoS ONE;2011, Vol. 6 Issue 9, p1 

    We have previously demonstrated that gene therapy can rescue the phenotype and extend lifespan in the delta-sarcoglycan deficient cardiomyopathic hamster. In patients with similar genetic defects, steroids have been largely used to slow down disease progression. Aim of our study was to evaluate...

  • Experimental Assessment of the Role of Acetaldehyde in Alcoholic Cardiomyopathy. Aberle II, Nicholas S.; Ren, Jun // Biological Procedures Online;2008, Vol. 10 Issue 1, p1 

    The article presents a study which described a video-based edge-detection technique with simultaneous measurement of intracellular calcium homeostasis in isolated ventricular myocytes. An introduction to alcoholic cardiomyopathy (ACA) is offered. Details of the materials and methods of the study...

  • P687 Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy. Mavroidis, M; Davos, C; Varela, A; Kostavasili, I; Tsilafakis, K; Vater, A; Van Tintelen, J P; Capetanaki, Y // Cardiovascular Research;Jul2014, Vol. 103 Issue suppl_1, pS125 

    Objectives, Background: Inflammation may contribute to disease progression in arrhythmogenic cardiomyopathy (AC) however, its role in this process is unresolved. Our goal was to delineate the pathogenic role of the complement system in a new animal model of AC and its involvement in human...

  • Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice. Han Wu; Guan-Nan Li; Jun Xie; Ran Li; Qin-Hua Chen; Jian-Zhou Chen; Zhong-Hai Wei; Li-Na Kang; Biao Xu; Wu, Han; Li, Guan-Nan; Xie, Jun; Li, Ran; Chen, Qin-Hua; Chen, Jian-Zhou; Wei, Zhong-Hai; Kang, Li-Na; Xu, Biao // BMC Cardiovascular Disorders;1/11/2016, Vol. 16, p1 

    Background: Myocardial fibrosis is an essential hallmark of diabetic cardiomyopathy (DCM) contributing to cardiac dysfunctions. Resveratrol, an antioxidant, exerts its anti-fibrotic effect via inhibition of oxidative stress, while the underlying molecular mechanism remains largely...

  • Anti-inflammatory IL-10 is upregulated in both hemispheres after experimental ischemic stroke: Hypertension blunts the response. Fouda, Abdelrahman Y.; Kozak, Anna; Alhusban, Ahmed; Switzer, Jeffrey A.; Fagan, Susan C. // Experimental & Translational Stroke Medicine;2013, Vol. 5 Issue 1, p2 

    Background Exogenous administration of the anti-inflammatory cytokine, interleukin 10 (IL-10), is known to promote neuroprotection and mitigate neuroinflammation after ischemia. However, endogenous expression and localization of IL-10 and its receptor (IL-10R) in the postischemic brain are still...

  • Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats. Cook, H. Terence; Singh, Sharon J.; Wembridge, David E.; Smith, Jennifer; Tam, Frederick W.K.; Pusey, Charles D. // Kidney International;Apr1999, Vol. 55 Issue 4, p1319 

    Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats. Background. Activated macrophages play a central role in crescentic glomerulonephritis. Interleukin-4 (IL-4) down-regulates many macrophage proinflammatory activities. We therefore studied the effect of IL-4 on...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics